CNP Q1 2026 Earnings Slight EPS Miss Amidst Operational Progress RWT Q1 2026 Earnings EPS Misses Estimates Despite Positive Market Reaction XRN Q1 2026 Earnings Significant EPS Miss Highlights Ongoing Challenges NMRA Q1 2026 Earnings NarrowerthanExpected Loss Reflects Disciplined Spending CleanSpark CLSK Q1 2026 Earnings Deep EPS Miss Fails to Dampen Investor Sentiment PDS Biotechnology Q1 2026 Earnings Narrowed Loss Per Share and Clinical Progress Drive Positive Market Response